How Omega-3 and Omega-6 Fats May Support Brain Health in Neurodegenerative Conditions

This review article examines research on two families of polyunsaturated fatty acids—omega-3s (EPA and DHA) and omega-6s (linoleic acid, GLA, and arachidonic acid)—and their potential roles in neurodegenerative diseases such as Alzheimer’s, Parkinson’s, Huntington’s, ALS, and multiple sclerosis. These conditions share common features including inflammation in the nervous system, loss of neurons, and oxidative stress, resembling autoimmune-type processes.

The authors summarize how omega-3 fatty acids appear to influence inflammation, gene activity, cell membrane function, immune cell behavior, and cell signaling pathways. In contrast, the omega-6 fatty acids reviewed show more mixed effects—arachidonic acid is generally linked to promoting inflammation, while other omega-6 compounds like GLA may have some neuroprotective properties, making their overall role less clear-cut than omega-3s.

The paper compiles findings from existing clinical trials, looking at the doses and study durations used when testing these fatty acids as potential therapeutic approaches for chronic neurodegenerative and inflammatory conditions, without drawing new experimental conclusions of its own.